University of Minnesota — Minneapolis, Minnesota

Public research footprint of University of Minnesota, compiled from the ClinicalTrials.gov public registry.

3,332

Registered studies

780

Active

459

Recruiting now

1,963

Completed

512

Stopped or withdrawn

Most-studied conditions

Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Multiple Myeloma · Recurrent Malignant Uterine Corpus Neoplasm · Botryoid-Type Embryonal Rhabdomyosarcoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)
NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Minnesota?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.